Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

0.7815 +0.0295 (+3.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 267,339
Open 0.7559
Bid (Size) 0.7525 (13)
Ask (Size) 0.8500 (42)
Prev. Close 0.7520
Today's Range 0.7402 - 0.7835
52wk Range 0.6600 - 3.090
Shares Outstanding 124,094,390
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's pre-market session
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga

Performance

YTD
-53.8%
-53.8%
1 Month
+9.5%
+9.5%
3 Month
-0.1%
-0.1%
6 Month
-57.5%
-57.5%
1 Year
-69.1%
-69.1%

More News

Read More
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Earnings Scheduled For April 29, 2025
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024
Via InvestorPlace
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From Nautilus Biotechnology Inc.
Via GlobeNewswire
NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024
Via InvestorPlace
Nautilus Biotechnology Reports First Quarter 2024 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From Nautilus Biotechnology Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Nautilus Biotechnology, Inc. - Common Stock publicly traded?
Yes, Nautilus Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Nautilus Biotechnology, Inc. - Common Stock trade on?
Nautilus Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nautilus Biotechnology, Inc. - Common Stock?
The ticker symbol for Nautilus Biotechnology, Inc. - Common Stock is NAUT on the Nasdaq Stock Market
What is the current price of Nautilus Biotechnology, Inc. - Common Stock?
The current price of Nautilus Biotechnology, Inc. - Common Stock is 0.7815
When was Nautilus Biotechnology, Inc. - Common Stock last traded?
The last trade of Nautilus Biotechnology, Inc. - Common Stock was at 07/11/25 04:00 PM ET
What is the market capitalization of Nautilus Biotechnology, Inc. - Common Stock?
The market capitalization of Nautilus Biotechnology, Inc. - Common Stock is 96.98M
How many shares of Nautilus Biotechnology, Inc. - Common Stock are outstanding?
Nautilus Biotechnology, Inc. - Common Stock has 97M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.